Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Bergeron

Showing results (111-120 of 114) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 114 results.
Structure (London, England : 1993)|February 17, 2015
Structure of EspB from the ESX-1 type VII secretion system and insights into its export mechanismMatthew Solomonson, Dheva Setiaputra, Karl A T Makepeace, et al.
Molecular Psychiatry|December 10, 2008
Targeted disruption of serine racemase affects glutamatergic neurotransmission and behaviorA C Basu, G E Tsai, C-L Ma, et al.
Diabetologia|January 12, 2012
Chronic treatment with a glucokinase activator delays the onset of hyperglycaemia and preserves beta cell mass in the Zucker diabetic fatty ratM Futamura, J Yao, X Li, et al.
Clinical Pharmacology and Therapeutics|November 5, 2010
Dipeptidyl peptidase-4 inhibitors administered in combination with metformin result in an additive increase in the plasma concentration of active GLP-1E M Migoya, R Bergeron, J L Miller, et al.
Pageof 12

Showing results (111-120 of 114) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 114 results.
Structure (London, England : 1993)|February 17, 2015
Structure of EspB from the ESX-1 type VII secretion system and insights into its export mechanismMatthew Solomonson, Dheva Setiaputra, Karl A T Makepeace, et al.
Molecular Psychiatry|December 10, 2008
Targeted disruption of serine racemase affects glutamatergic neurotransmission and behaviorA C Basu, G E Tsai, C-L Ma, et al.
Diabetologia|January 12, 2012
Chronic treatment with a glucokinase activator delays the onset of hyperglycaemia and preserves beta cell mass in the Zucker diabetic fatty ratM Futamura, J Yao, X Li, et al.
Clinical Pharmacology and Therapeutics|November 5, 2010
Dipeptidyl peptidase-4 inhibitors administered in combination with metformin result in an additive increase in the plasma concentration of active GLP-1E M Migoya, R Bergeron, J L Miller, et al.
Pageof 12